Clinical Trial Results:
            An Eight-Week, Multinational, Multicenter, Randomized, Double-blind, Placebo-controlled Study, with Escitalopram as an Active Control, to Evaluate the Efficacy, Safety and Tolerability of a Saredutant 100 mg Dose Once Daily, in Elderly Patients with Major Depressive Disorder 
    
| 
                 Summary 
         | 
        |
    EudraCT number  | 
        2006-003793-94 | 
    Trial protocol  | 
        CZ SE FR | 
    Global completion date  | 
        
                                    12 Feb 2008
                             
         | 
    
| 
                 Paediatric regulatory details 
         | 
        |
    Is the trial part of an agreed EMA paediatric investigation plan?  | 
        
                                        No
                                 
         | 
    
    Is the trial in scope of article 45 of Regulation (EC) No 1901/2006?  | 
        
                                        No
                                 
         | 
    
    Is the trial in scope of article 46 of Regulation (EC) No 1901/2006?  | 
        
                                        No
                                 
         | 
    
| 
                 Results information 
         | 
        |
    Results version number  | 
        v1(current) | 
    This version publication date  | 
        
                                    04 Jun 2016
                             
         | 
    
    First version publication date  | 
        
                                    04 Jun 2016
                             
         | 
    
    Other versions  | 
        |
    Summary report(s)  | 
                                EFC5574 | 
    
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.